Background: Acquired resistance to various drugs is a key challenge for anticancer therapy. Earlier we have revealed a selective apoptosis of tumor cells induced by polyvalent cationic peptides (CPs) both in vitro and in vivo by inactivation their cell targets -multifunctional chaperone proteins nucleolin (NCL) and nucleophosmin (NPM). Here we applied Arg/ Lys-enriched CPs as well as CPs, conjugated with Doxorubicin (Dox) to induce cell death by nucleolar stress mechanisms both in Dox-sensitive breast cancer (BC) cells and in Dox-resistant ones. Molecular interactions between CP as ligand and cellular targets using computer modeling by docking have been done. Then, CP potential for anticancer therapy of various malignant tumors is discussed.Objective: An analysis of cell survival in breast cancer (BC) sublines that are sensitive or resistant to Doxorubicin (Dox) by cationic peptides (CPs) and conjugate CP +Dox. Results:The data indicate that Arg/Lys enriched CPs might be perspective agents for inducing BC cell apoptosis and for transport Dox or other drugs in tumor cells to overcome drug resistance. Conclusion:Molecular docking is effective tool for modeling and evaluating of interactions and competitive binding of CPs to their cellular targets. This approach is also useful for design novel peptides with high anticancer properties and low toxicity for patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.